Vaccination and autoimmune rheumatic diseases

Autoimmunity Reviews

Volumn 8, Issue 2, 2008, Pages 124-128

  Conti, Fabrizio ^a   Rezai, Soheila ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Influenza vaccine; Pneumococcal vaccine; Rheumatoid arthritis; Systemic lupus erythematosus; TNF blocking agents

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INFLUENZA VACCINE; INTERFERON; METHOTREXATE; PNEUMOCOCCUS VACCINE; PREDNISONE; RITUXIMAB; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AUTOIMMUNE DISEASE; CLINICAL TRIAL; DRUG SAFETY; GLOMERULONEPHRITIS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VACCINATION;

HUMANS; INFECTION; INFLUENZA VACCINES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PNEUMOCOCCAL VACCINES; RHEUMATIC DISEASES; VACCINATION;

EID: 56349125367     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.007     Document Type: Review

References (40)

1. Chen R.T., Pless R., and DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 16 (2001) 309-318
2. Older A., Battafarano D.F., Enzenauer R.J., and Krieg A. Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum 29 (1999) 131-139
3. Shoenfeld Y., and Aron-Maor A. Vaccination as an additional player in the mosaic autoimmunity. J Autoimmun 14 (2000) 1-10
4. Urowitz M.B., Gladman D.D., Abu-Shakra M., and Farewell V.T. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol 24 (1997) 1061-1065
5. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 24 (1996) 423 456
6. Conti F., Rezai S., and Valesini G. Vaccination and rheumatic diseases: is there still a dilemma?. Curr Rheumatol Rev 3 (2007) 79-91
7. Ayvazian L.F., and Badger T.L. Disseminated lupus erythematosus occurring among student nurses. N Engl J Med 239 (1948) 565-570
8. Williams G.W., Steinberg A.D., Reinertsen J.R., Klassen L.W., Decker J.L., and Dolin R. Influenza immunization systemic lupus erythematosus. Ann Intern Med 88 (1978) 729-735
9. Brodman R., Gilfillan R., Glass D., and Schur P.H. Influenza vaccine response in SLE. Ann Intern Med 88 (1978) 735-741
10. Louie J.S., Nies K.M., Shoji K.T., Fraback R.C., Abrass C., Border W., et al. Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med 88 (1978) 790-792
11. Ristow S.C., Douglas R.G., and Condemi J.J. Influenza vaccination of patients with systemic lupus erythematosus. Ann Intern Med 88 (1978) 786-789
12. Herron A., Dettleff G., Hixon B., Brandwin L., Ortbals D., Hornick R., et al. Influenza vaccination in patients with rheumatic diseases. JAMA 242 (1979) 53-56
13. Turner-Stokes L., and Isenberg D.A. Leading article: immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 47 (1988) 529-531
14. Abu-Shakra M., Zalmanson S., Neumann L., Flusser D., Sukenik S., and Buskila D. Influenza virus vaccination of patients with SLE: effects on the disease activity. J Rheumatol 27 (2000) 1681-1685
15. Abu-Shakra M., Press J., Varsano N., Levy V., Mendelson E., Sukenik S., et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 29 (2002) 2555-2557
16. Abu-Shakra M., Press J., Sukenik S., and Buskila D. Influenza virus vaccination of patient with SLE: effects on generation of autoantibodies. Clin Rheumatol 21 (2002) 369-372
17. Mercado U., Acosta H., and Avendano L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 56 1 (2004) 16-20
18. Holvast A., Huckriede A.L., Wilschut J., Horst G., De Vries J.J., Benne C.A., et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65 (2006) 913-918
19. Del Porto F., Laganá B., Biselli R., Donatelli I., Campitelli L., Nisini R., et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis: safety and immunogenicity. Vaccine 24 (2006) 3217-3223
20. Klippel J.H., Karsh J., Stahl N., Decker J.L., Steinberg A.D., and Schiffman G. A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 22 (1979) 1321-1325
21. Jarrett M.P., Schiffman G., Barland P., and Grayzel A.I. Impaired response to pneumococcal vaccine in SLE. Arthritis Rheum 23 (1980) 1287-1293
22. Lipnick R.N., Karsh J., Stahl N.I., Blackwelder W.C., Schiffman G., and Klippel J.H. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 12 (1985) 1118-1121
23. Battafarano D.F., Battafarano N.J., Larsen L., Dyer P.D., Older S.A., Muehlbauer S., et al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 41 (1998) 1828-1834
24. Elkayam O., Paran D., Caspi D., Litinsky I., Yaron M., Charboneau D., et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Infect Dis 34 (2002) 147-153
25. Tarján P., Sipka S., Maródi L., Nemes E., Lakos G., Gyimesi E., et al. No short-term immunological effects of pneumococcus vaccination in patients with systemic lupus erythematosus. Scand J Rheumatol 31 (2002) 211-215
26. Doran M.F., Crowson C.S., Pond G.R., O'Fallon W.M., and Gabriel S.E. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46 (2002) 2287-2293
27. Vautier G., and Carty J.E. Acute sero-positive rheumatoid arthritis occurring after hepatitis B vaccination. Br J Rheumatol 33 (1994) 991-998
28. Pope J.E., Stevens A., Howson W., and Bell D.A. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 25 (1998) 1687-1693
29. Chalmers A., Scheifele D., Patterson C., Williams D., Weber J., Shuckett R., et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 21 (1994) 1203-1206
30. Cimmino M.A., Seriolo B., and Accardo S. Influenza vaccination in rheumatoid arthritis. J Rheumatol 22 (1995) 1802-1803
31. Fomin I., Caspi D., Levy V., Varsano N., Shalev Y., Paran D., et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF a blockers. Ann Rheum Dis 65 (2006) 191-194
32. Kaine J.L., Kivitz A.J., Birbara C., and Luo A.Y. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 34 (2007) 272-279
33. Kubota T., Nii T., Nanki T., Kohsaka H., Harigai M., Komano Y., et al. Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Mod Rheumatol 17 (2007) 531-533
34. Gelinck L.B., Teng Y.K., Rimmelzwaan G.F., van den Bemt B.J., Kroon F.P., and van Laar J.M. Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 66 (2007) 1402-1403
35. Oren S., Mandelboim M., Braun-Moscovici Y., Paran D., Ablin J., Litinsky I., et al. Vaccination against influenza in rheumatoid arthritis patients: the effect of rituximab on the humoral response. Ann Rheum Dis 67 (2008) 937-941
36. Elkayam O., Caspi D., Reitblatt T., Charboneau D., and Rubins J.B. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 33 (2004) 283-288
37. Kapetanovic M.C., Saxne T., Sjöholm A., Truedsson L., Jönsson G., and Geborek P. Influenza of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 45 (2006) 106-111
38. Visvanathan S., Keenan G.F., Baker D.G., Levison A.I., and Wagner C.L. Response to the pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 34 (2007) 952-957
39. St Clair E.W., van der Heijde D.M., Smolen J.S., Maini R.N., Bathon J.M., Emery P., et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50 (2004) 3432-3443
40. BSR. National guidelines for the monitoring of second line drugs (2000), British Society for Rheumatology, London